Parkin-proven disease: Common founders but divergent phenotypes

Neurology

Volumn 60, Issue 10, 2003, Pages 1605-1610

  Lincoln, S ^a   Wiley, J ^f   Lynch, T ^f   Langston, J W ^e   Chen, R ^e   Lang, A ^g   Rogaeva, E ^g   Sa, D S ^g   Munhoz, R P ^g   Harris, J ^b   Marder, K ^c   Klein, C ^h   Bisceglio, G ^a   Hussey, J ^a   West, A ^a   Hulihan, M ^a   Hardy, J ^d   Farrer, M ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c Taub Inst Res Alzheimer's Dis A   (United States)

^d NATIONAL INSTITUTE ON AGING   (United States)

^e PARKINSON S INSTITUTE   (United States)

^f UNIVERSITY COLLEGE DUBLIN   (Ireland)

^g UNIVERSITY OF TORONTO   (Canada)

^h UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PARKIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; FOUNDER EFFECT; GENE DELETION; GENE FUNCTION; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HUMAN; INHERITANCE; MALE; ONSET AGE; PARKINSONISM; PRIORITY JOURNAL;

EID: 0038137238     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000064289.49410.A9     Document Type: Article

References (24)

1. Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998;392: 605-608.
2. Lücking C, Dürr A, Bonifati V, et al. Association between early-onset Parkinson's disease and mutations in the parkin gene. French Parkinson's Disease Genetics Study Group. N Engl J Med 2000;342:1560-1567.
3. Ishikawa A, Tsuji S. Clinical analysis of 17 patients in 12 Japanese families with autosomal-recessive type juvenile parkinsonism. Neurology 1996;47:160-166.
4. Abbas N, Lücking CB, Ricard S, et al. A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. Hum Mol Genet 1999;8:567-574.
5. West A, Periquet M, Lincoln S, et al. The complex relationship between parkin mutations and Parkinson's disease. Am J Med Genet 2002;114: 584-591.
6. Klein C, Pramstaller PP, Kis B, et al. Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: expanding the phenotype. Ann Neurol 2000;48:65-71.
7. Ishikawa A, Takahashi H. Clinical and neuropathological aspects of autosomal recessive juvenile parkinsonism. J Neurol 1998;245:4-9.
8. Mori H, Kondo T, Yokochi M, et al. Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q. Neurology 1998;51: 890-892.
9. Farrer M, Chan P, Chen R, et al. Lewy bodies and parkinsonism in families with parkin mutations. Ann Neurol 2001;50:293-300.
10. van de Warrenburg BP, Lammens M, Lucking CB, et al. Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations. Neurology 2001;56:555-557.
11. Shimura H, Hattori N, Kubo S, et al. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet 2000;25:302-305.
12. Fishman PS, Oyler GA. Significance of the parkin gene and protein in understanding Parkinson's disease. Curr Neurol Neurosci Rep 2002;2: 296-302.
13. Shimura H, Schlossmacher MG, Hattori N, et al. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Science 2001;293:263-269.
14. Pterucelli L, Ved R, Kehoe K, et al. Tau is a target for the E3 ligase activity of parkin. Soc Neurosci 2002;118.2:53.
15. Hedrich K, Marder K, Harris J, et al. Evaluation of 50 probands with early-onset Parkinson's disease for parkin mutations. Neurology 2002; 58:1239-1246.
16. Wiley J, Lynch T, Lincoln S, et al. Parkinson's disease in Ireland: clinical and genetic heterogeneity in parkin-proven disease. Neurology 2002;submitted.
17. Fahn SER, members of the UPDRS Development Committee. Recent developments in Parkinson's disease New York: Macmillan, 1987.
18. Nickerson DA, Tobe VO, Taylor SL. PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic Acids Res 1997;25:2745-2751.
19. Periquet M, Lucking C, Vaughan J, et al. Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from founder effects. Am J Hum Genet 2001;68:617-626.
20. Hilker R, Klein C, Ghaemi M, et al. Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene. Ann Neurol 2001;49: 367-376.
21. West AB, Maraganore D, Crook J, et al. Functional association of the parkin gene promoter with idiopathic Parkinson's disease. Hum Mol Genet 2002;11:2787-2792.
22. Yamamura Y, Arihiro K, Kohriyama T, Nakamura S. Early-onset parkinsonism with diurnal fluctuation - clinical and pathological studies. Rinsho Shinkeigaku 1993;33:491-496.
23. Takahashi H, Ohama E, Suzuki S, et al. Familial juvenile parkinsonism: clinical and pathologic study in a family. Neurology 1994;44:437-441.
24. Walters KJ, Kleijnen MF, Goh AM, et al. Structural studies of the interaction between ubiquitin family proteins and proteasome subunit S5a. Biochemistry 2002;41:1767-1777.